Impact of Mobile COVID-19 Laboratory Testing on Readiness of US Army 1/34th Armored Brigade Combat Team, 34th Infantry Division Deployment to National Training Center, Fort Irwin, CA.

INTRODUCTION: The emergence of the novel severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) rapidly evolved into a worldwide pandemic of Coronavirus Disease 2019 (COVID-19). The pandemic had a major operational impact upon the US military, requiring interventions to mitigate transmission risk resulting in DoD-wide disruption of daily operations, restriction of movement, and delays in training. Development of a rapid mobile COVID-19 testing strategy was pursued as a means to allow service members to complete critical missions in select settings. In this report, we describe the first of its kind mobile medical laboratory (MML) that allowed for testing of approximately 4,000 soldiers of the 1/34th Armored Brigade Combat Team (1/34th ABCT), 34th Infantry Division, prior to deployment for validation exercises to the National Training Center, Fort Irwin, CA. We describe the utilizing of the MML, COVID-19 testing workflow, clinical symptom data/cycle threshold (Ct) data from positive patients, and outcomes from this testing mission.

Remote monitoring of the progression of primary pneumonic plague in Brown Norway rats in high-capacity, high-containment housing.

Development of new vaccines, diagnostics, and therapeutics for biodefense or other relatively rare infectious diseases is hindered by the lack of naturally occurring human disease on which to conduct clinical trials of efficacy. To overcome this experimental gap, the U.S. Food and Drug Administration established the Animal Rule, in which efficacy testing in two well-characterized animal models that closely resemble human disease may be accepted in lieu of large-scale clinical trials for diseases with limited natural human incidence. In this report, we evaluated the Brown Norway rat as a model for pneumonic plague and describe the natural history of clinical disease following inhalation exposure to Yersinia pestis. In high-capacity, high-containment housing, we monitored temperature, activity, heart rate, and rhythm by capturing electronic impulses transmitted from abdominal telemeter implants. Using this system, we show that reduced activity and development of fever are sensitive indications of disease progression. Furthermore, we identified heart arrhythmias as contributing factors to the rapid progression to lethality following the fever response. Together, these data validate the Brown Norway rat as an experimental model for human pneumonic plague and provide new insight that may ultimately lead to novel approaches in postexposure treatment of this devastating infection.